Catherine Wood's CAI Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 408,725 shares of Caris Life Sciences, Inc. (CAI) worth $11.03 M, representing 0.07% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Catherine Wood has maintained this position in CAI for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 198,300 shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Caris Life Sciences (CAI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Caris Life Sciences (CAI) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +163,375 | Add 66.59% | 408,725 | $26.98 |
| Q3 2025 | +198,300 | Add 421.47% | 245,350 | $30.25 |
| Q2 2025 | +47,050 | New Buy | 47,050 | $26.72 |
Catherine Wood's Caris Life Sciences Investment FAQs
Catherine Wood first purchased Caris Life Sciences, Inc. (CAI) in Q2 2025, acquiring 47,050 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Caris Life Sciences, Inc. (CAI) for 3 quarters since Q2 2025.
Catherine Wood's largest addition to Caris Life Sciences, Inc. (CAI) was in Q3 2025, adding 245,350 shares worth $7.42 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 408,725 shares of Caris Life Sciences, Inc. (CAI), valued at approximately $11.03 M.
As of the Q4 2025 filing, Caris Life Sciences, Inc. (CAI) represents approximately 0.07% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Caris Life Sciences, Inc. (CAI) was 408,725 shares, as reported at the end of Q4 2025.